水に溶けないカンプトセチンの抗がん剤のリポソーマの核負荷のための多用途のプロドラッグアプローチ
Xinli Liu1, Bert C Lynn, Junhong Zhang
1Department of Chemistry and Pharmaceutical Sciences, Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA.
Journal of the American Chemical Society
|June 27, 2002
まとめ
新しい前薬剤戦略により,水溶性カンプトテチンのリポソーマル負荷が可能になる. このアプローチは,腫瘍を標的とし,腫瘍部位で活性カンプトセチンの制御された放出を促進します.
科学分野:
- 製薬化学 製薬化学について
- 薬物の配送システムです.
- ナノテクノロジー ナノテクノロジー
背景:
- カンプトセチンは強力な抗がん剤で,水溶性が低いため,臨床応用が制限されています.
- リポソーム製剤は,薬剤の溶解性と投与を改善するための戦略を提供します.
- 水に溶けない薬剤を効率的にリポソームに詰め込むことは,依然として課題です.
研究 の 目的:
- 水に溶けないカンプトテチンをリポソームに効果的にロードするための汎用性のある前薬戦略を開発する.
- 腫瘍部位で活性薬の放出を促進する前薬システムを作成する.
- リポフィルカンプトセチンのアナログの腫瘍標的投与を可能にするために.
主な方法:
- 活性カンプトセチンのアナログをオメガ-アミノアルカノアニクエステル前薬に変換する.
- プロドラッグのアミノ群を利用して,脂質体負荷のための水溶性およびアンモニアム硫酸の梯度に対する反応性を高めます.
- 生理学的なpHで非酵素分解と活性薬の放出のための前薬の設計.
主要な成果:
- プロドラッグ戦略は,カンプトテチンのアクティブロードをリポソーマ水中核にうまく促進しました.
- 前薬は,生理学的なpH (≥7) でサイクリングと急速な非酵素分解を経験し,活性カンプトセチンを放出します.
- 活性剤形成の速度は,アルキルスペーサーの長さ (n) を変化させることで調節することができます.
結論:
- この新しいリポソーマル前薬剤戦略は,SN-38,9-ニトロカンプトセチン,DB-67を含む水に溶けないカンプトセチンを投与するための多用途なシステムを提供します.
- このアプローチは,制御可能な薬剤の放出キネティクスを持つ標的型腫瘍治療の可能性を秘めています.
- この方法は,カンプトセチンの類似体の溶解性が低いことに関連した制限を克服します.
関連する概念動画
Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


